Oculis Holding AG (OCS) Other Income (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Other Income of $724061.7 for Q1 2026, up 141.54% year-over-year from $299764.4 in Q1 2025, and up 496.61% quarter-over-quarter from $121363.5 in Q4 2025.

Oculis Holding AG (OCS) Other Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Income history runs 5 years deep, the most recent figure standing at $724061.7 for Q1 2026.

  • In Q1 2026, Other Income rose 141.54% year-over-year to $724061.7; the TTM figure through Mar 2026 stood at $2.5 billion (up 213.18% YoY), while the FY2025 annual figure was -$7.4 million, down 611.22% from the prior year.
  • Other Income for Q1 2026 stood at $724061.7, up from $121363.5 in the prior quarter.
  • The five-year high for Other Income was $2.5 billion in Q3 2025, with the low at -$2.2 billion in Q3 2024.
  • The 5-year median for Other Income is -$278984.7 (2023), against an average of $20.2 million.
  • Peak annual rise in Other Income reached 882.33% in 2024, while the deepest fall reached 72670.47% in 2024.
  • Oculis Holding AG's Other Income stood at -$1.3 million in 2022, then plunged by 82.21% to -$2.5 million in 2023, then jumped by 175.75% to $1.9 million in 2024, then plunged by 93.48% to $121363.5 in 2025, then jumped by 496.61% to $724061.7 in 2026.
  • Business Quant data shows OCS's Other Income at $724061.7 in Q1 2026, $121363.5 in Q4 2025, and $2.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Oculis Holding AG 879.09 Mn 590.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 724,061.65
Dec 31, 2025 121,363.47
Sep 30, 2025 2.47 Bn
Jun 30, 2025 -5.72 Mn
Mar 31, 2025 -1.74 Mn
Dec 31, 2024 1.86 Mn
Sep 30, 2024 -2.18 Bn
Jun 30, 2024 -295,246.86
Mar 31, 2024 2.06 Mn
Dec 31, 2023 -2.46 Mn
Sep 30, 2023 -2.99 Mn
Jun 30, 2023 453,767.62
Mar 31, 2023 -262,722.51
Sep 30, 2022 -1.35 Mn